(Q34665366)

3 August 2017

title

Two-year clinical outcome after carvedilol-loaded stent implantation in patients with coronary artery disease (English)

1 reference

3 August 2017

main subject

coronary artery disease

1 reference

15

Youngkeun Ahn

1 reference

3 August 2017

Hyun Kuk Kim

1

1 reference

3 August 2017

Young Joon Hong

2

1 reference

3 August 2017

Myung Ho Jeong

3

1 reference

3 August 2017

Weon Kim

4

1 reference

3 August 2017

Sung Soo Kim

5

1 reference

3 August 2017

Jum Suk Ko

6

1 reference

3 August 2017

Min Goo Lee

7

1 reference

3 August 2017

Doo Sun Sim

8

1 reference

3 August 2017

Keun Ho Park

9

1 reference

3 August 2017

Nam Sik Yoon

10

1 reference

3 August 2017

Hyun Ju Yoon

11

1 reference

3 August 2017

Kye Hun Kim

12

1 reference

3 August 2017

Hyung Wook Park

13

1 reference

3 August 2017

Ju Han Kim

14

1 reference

3 August 2017

Jeong Gwan Cho

16

1 reference

3 August 2017

Jong Chun Park

17

1 reference

3 August 2017

Jung Chaee Kang

18

1 reference

3 August 2017

publication date

2 March 2011

1 reference

The Korean journal of internal medicine

3 August 2017

published in

1 reference

3 August 2017

volume

26

1 reference

3 August 2017

issue

1

1 reference

3 August 2017

page(s)

41-46

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

3 August 2017

copyright license

start time

1 January 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Molecular basis of restenosis and novel issues of drug-eluting stents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056254

Clinical end points in coronary stent trials: a case for standardized definitions

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056254

Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056254

A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056254

Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056254

Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056254

A paclitaxel-eluting stent for the prevention of coronary restenosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056254

Carvedilol, a novel vasodilating beta-blocker with the potential for cardiovascular organ protection

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056254

Carvedilol, a cardiovascular drug, prevents vascular smooth muscle cell proliferation, migration, and neointimal formation following vascular injury

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056254

Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056254

Carvedilol inhibits platelet-derived growth factor-induced extracellular matrix synthesis by inhibiting cellular reactive oxygen species and mitogen-activated protein kinase activation.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056254

Probucol inhibits in-stent thrombosis and neointimal hyperplasia by promoting re-endothelialization.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056254

Effect of anti-oxidant (carvedilol and probucol) loaded stents in a porcine coronary restenosis model

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056254

Carvedilol Inhibits Vascular Smooth Muscle Cell Proliferation

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056254

Acute and chronic tissue response to coronary stent implantation: pathologic findings in human specimen

26 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21437161

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21437161

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Pathology of Acute and Chronic Coronary Stenting in Humans

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21437161

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3904/KJIM.2011.26.1.41

1 reference

3 August 2017

1 reference

3 August 2017

1 reference